EYS-809

N/A

Report date: 2024/09/26 15:34:03

Base Information

Drug NameEYS-809
Drug Alias NameEYS-809
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionGene transferenceVascular endothelial growth factor A inhibitors
TargetsVascular endothelial growth factor A
Therapy Area/IndicationsDiabetic macular oedemaRetinal Vein OcclusionWet age-related macular degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEyevensys SAS
China Registration ClassN/A

Develop Information

Active CompaniesEyevensys SAS
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaRetinal Vein OcclusionWet age-related macular degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A